Clinical and Molecular Study of Endometriosis and Adenomyosis
Recruiting · NCT04481321 · Observational (researchers observe without assigning treatment) · Lead sponsor: Assistance Publique - Hôpitaux de Paris
View the official record on ClinicalTrials.gov →Interventions studied
Biological/Vaccine
What this trial is about
The purpose of this study is to determine whether endometriosis and adenomyosis are progressive diseases, in terms of symptoms (pain, abnormal uterine bleeding and infertility), anatomical lesions size, and recurrences. We also aimed to address molecular questions on immune dialogues between ectopic lesions and the eutopic endometrium, auto-immunity in endometriosis and adenomyosis and the role of the microbiota in their respective pathophysiologies.
Who can take part
Age range
18 Years to 42 Years
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Women of age between - 18 and 42 years old.
- In-service care for one of the pelvic pain and/or infertility, or for a pelvic mass.
- Having a radiological diagnosis made by a referral practitioner and/or operated in the department
Exclusion criteria
- HIV-positive women, HBV and HCV
- During pregnancy
- Having a cancer diagnosis
- Refusing to sign a consent.
Where it is running
1 location listed.
- Port Royal, hospital cochin - Paris, France